Highlights India’s advances in pharmacopoeial science, regulatory standards, and global harmonization efforts at the 16th International Meeting of World Pharmacopoeias
Dengue, a mosquito-borne viral disease, is emerging as a growing public health threat across Africa
Exclusive Asia-Pacific licensing agreement for Bejescin strengthens the company’s nephrology and autoimmune disease portfolio
The move signals a major expansion milestone for the Swiss laboratory automation company
Growth driven by strong performance across Sugar Free, RiteBite Max Protein, Everyuth, Glucon-D and Nutralite portfolios
The drug also delivered a disease control rate (DCR) of 83.3% in high-dose cohorts and a mean progression-free survival of 6.3 months in SCLC patients
Company enters women’s personal grooming segment while strengthening pain management portfolio with herbal Ortho Oil
The company posted revenue of €1,267 million, up 6% on a constant currency basis
American College of Cardiology and Korean Society of Cardiology convene global experts to address rising cardiometabolic burden
The JADE trial enrolled 164 U.S. patients who initially received three monthly doses of OLN324 or faricimab, followed by 12 weeks off treatment with retreatment allowed only if disease recurred
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
